Switching from Gilenya to Lemtrada could trigger MS activity
According to research, switching treatments from Gilenya (fingolimod) to Lemtrada (alemtuzumab) can trigger significant and unexpected disease activity in MS patients...Read more - http://www.ms-uk.org/switching-gilenya- ... ity-070217
Switching from Gilenya to Lemtrada could trigger MS activity
Switching from Gilenya to Lemtrada could trigger MS activity
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1211 Views
-
Last post by frodo
-
- 0 Replies
- 1014 Views
-
Last post by frodo
-
- 0 Replies
- 1067 Views
-
Last post by NHE
-
- 1 Replies
- 1532 Views
-
Last post by ElliotB
-
- 5 Replies
- 13744 Views
-
Last post by gibbledygook